Abstract
Background: Robotic surgery is increasingly used for various types of operations, including those for cancers; however, its application for pancreatic cancer resection is still controversial because of safety concerns, particularly about the risk of intraoperative bleeding. Although robotic pancreatoduodenectomy is not contraindicated for pancreatic cancers with superior mesenteric vein (SMV) abutment, surgeons must take a careful approach to prevent potentially critical bleeding during SMV dissection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.